4//SEC Filing
LeBel Carl 4
Accession 0001127602-21-001992
CIK 0001703647other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 5:01 PM ET
Size
5.1 KB
Accession
0001127602-21-001992
Insider Transaction Report
Form 4
LeBel Carl
Chief Development Officer
Transactions
- Award
Stock Option
2021-01-15+75,000→ 75,000 totalExercise: $35.85Exp: 2031-01-14→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2021, and will be fully vested and exercisable on January 1, 2025.
Documents
Issuer
Frequency Therapeutics, Inc.
CIK 0001703647
Entity typeother
Related Parties
1- filerCIK 0001439275
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 5:01 PM ET
- Size
- 5.1 KB